Clinical Trial Update: A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique [Phase 2]

View source ↗

Summary

Phase II clinical trial update reporting safety and immunogenicity of an HIV vaccine regimen using DNA priming with ID Zetajet electroporation, with or without …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ID Derma Vax
• ID Zetajet
• Modified Vaccinia Ankara (MVA) vaccine (Modified Vaccinia Ankara (MVA) vaccine)

Snippet

Sponsor: Muhimbili University of Health and Allied Sciences | Conditions: Vaccines, HIV | Phase 2 | Status: COMPLETED